Connor, Clark & Lunn Investment Management Ltd. Novartis Ag Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $20 Billion
  • Q4 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Novartis Ag stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 8,433 shares of NVS stock, worth $953,603. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,433
Previous 191,317 95.59%
Holding current value
$953,603
Previous $22 Million 96.27%
% of portfolio
0.0%
Previous 0.12%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
SELL
$96.78 - $117.18 $17.7 Million - $21.4 Million
-182,884 Reduced 95.59%
8,433 $820,000
Q3 2024

Nov 08, 2024
BUY
$106.13 - $120.89 $12 Million - $13.7 Million
113,260 Added 145.1%
191,317 $22 Million
Q2 2024

Aug 09, 2024
BUY
$92.57 - $107.37 $6.21 Million - $7.2 Million
67,095 Added 612.07%
78,057 $8.31 Million
Q1 2024

May 09, 2024
SELL
$95.27 - $108.47 $6.31 Million - $7.19 Million
-66,251 Reduced 85.8%
10,962 $1.06 Million
Q4 2023

Feb 09, 2024
SELL
$92.27 - $101.54 $21 Million - $23.1 Million
-227,937 Reduced 74.7%
77,213 $7.8 Million
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $15.8 Million - $17.6 Million
-167,264 Reduced 35.41%
305,150 $31.1 Million
Q2 2023

Aug 10, 2023
BUY
$92.52 - $104.91 $15.7 Million - $17.8 Million
169,256 Added 55.83%
472,414 $47.7 Million
Q1 2023

May 09, 2023
SELL
$80.03 - $92.81 $25.4 Million - $29.4 Million
-316,774 Reduced 51.1%
303,158 $27.9 Million
Q4 2022

Feb 10, 2023
BUY
$75.55 - $92.52 $42 Million - $51.5 Million
556,154 Added 872.02%
619,932 $56.2 Million
Q3 2022

Nov 10, 2022
BUY
$74.61 - $87.26 $1.14 Million - $1.34 Million
15,339 Added 31.67%
63,778 $4.85 Million
Q2 2022

Aug 05, 2022
BUY
$80.52 - $93.75 $3.9 Million - $4.54 Million
48,439 New
48,439 $4.1 Million
Q1 2022

May 12, 2022
SELL
$80.11 - $90.62 $3.65 Million - $4.13 Million
-45,565 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$79.7 - $88.13 $3.63 Million - $4.02 Million
45,565 New
45,565 $3.99 Million
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $221,203 - $245,063
-2,693 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$80.93 - $91.1 $15,619 - $17,582
193 Added 7.72%
2,693 $235,000
Q1 2020

May 13, 2020
SELL
$70.67 - $99.01 $8.8 Million - $12.3 Million
-124,575 Reduced 98.03%
2,500 $206,000
Q4 2019

Feb 12, 2020
SELL
$84.35 - $95.37 $2.23 Million - $2.52 Million
-26,425 Reduced 17.21%
127,075 $12 Million
Q3 2019

Nov 13, 2019
BUY
$85.54 - $94.26 $11.2 Million - $12.3 Million
130,650 Added 571.77%
153,500 $13.3 Million
Q2 2019

Aug 07, 2019
SELL
$75.4 - $92.8 $6.36 Million - $7.83 Million
-84,350 Reduced 78.68%
22,850 $2.09 Million
Q1 2019

May 08, 2019
SELL
$75.32 - $86.15 $26.6 Million - $30.4 Million
-353,126 Reduced 76.71%
107,200 $10.3 Million
Q4 2018

Feb 12, 2019
BUY
$73.66 - $82.02 $22.5 Million - $25 Million
305,289 Added 196.91%
460,326 $39.5 Million
Q3 2018

Nov 13, 2018
BUY
$66.94 - $77.43 $10.4 Million - $12 Million
155,037 New
155,037 $13.4 Million
Q1 2018

May 14, 2018
SELL
$70.39 - $84.15 $4.15 Million - $4.96 Million
-58,900 Closed
0 $0
Q4 2017

Feb 09, 2018
SELL
$72.33 - $77.64 $5.24 Million - $5.63 Million
-72,475 Reduced 55.17%
58,900 $4.95 Million
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $9.74 Million - $10.2 Million
131,375
131,375 $11.3 Million

Others Institutions Holding NVS

# of Institutions
1,502
Shares Held
129M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $243B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email